-
1 Comment
Lumibird SA is currently in a long term uptrend where the price is trading 8.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
Finally, its free cash flow fell by 68.1% to $3M since the same quarter in the previous year.
Based on the above factors, Lumibird SA gets an overall score of 2/5.
| ISIN | FR0000038242 |
|---|---|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Exchange | PA |
| CurrencyCode | EUR |
| Market Cap | 265M |
|---|---|
| PE Ratio | 46.35 |
| Target Price | 12.5 |
| Beta | 1.01 |
| Dividend Yield | None |
Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two segments, Photonics and Medical. The company offers solid-state and diode lasers, fiber lasers, fiber lasers/amplifiers and components, Laser rangefinder and LiDAR wind doppler LiDAR, medical and ophthalmological equipment. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The company was incorporated in 1970 and is headquartered in Lannion, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LBIRD.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
